Only 33% of patients receiving cytotoxic chemotherapy for solid tumours received influenza vaccination in a 2001 UK study

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.427, 2003-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombocytopenia in Adult Cancer Patients Receiving Cytotoxic Chemotherapy: Results from a Retrospective Hospital-Based Cohort Study

By Berg Maarten J. ten   >   Shantakumar Sumitra  

Drug Safety, Vol. 34, Iss. 12, 2011-12 ,pp. : 1151-1160

Adis International

Access to resources Recommend Favorite

Chemotherapy-Associated Osteonecrosis in Cancer Patients with Solid Tumours: A Systematic Review

By Shim Katharine   MacKenzie Mary J.   Winquist Eric  

Drug Safety, Vol. 31, Iss. 5, 2008-01 ,pp. : 359-371

Adis International

Access to resources Recommend Favorite

Influenza vaccination programme worth it in the UK

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 370, 2002-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Administration of pegfilgrastim from the first cycle of chemotherapy reduces febrile neutropenia in elderly patients with solid tumours

By  

Reactions Weekly, Vol. 1, Iss. 1053, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

According to the MHRA, a total of 5 fatal ADR reports in patients receiving rimonabant [Acomplia] have been received in the UK

By  

Reactions Weekly, Vol. 1, Iss. 1206, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite